New research from a team of economists has estimated the legalization of medical and recreational cannabis over the past 25 years has cost pharmaceutical companies billions of dollars in lost sales.
Federal cannabis legalization might reduce conventional pharmaceutical sales by billions of dollars according to a new study conducted by researchers from California Polytechnic State University and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results